GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 7, 2020 at 8:22 PM.

  1. #1 cafead, Jul 7, 2020 at 8:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via GlaxoSmithKline is providing its pandemic adjuvant technology to another company to bolster the chances of developing a vaccine against COVID-19.

    This morning, the pharma giant announced a partnership with Canada’s Medicago to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system.

    article source
     
    Quote

Reply to Thread